Medpace Holdings (MEDP) Accumulated Depreciation & Amortization (2016 - 2025)
Medpace Holdings (MEDP) has disclosed Accumulated Depreciation & Amortization for 10 consecutive years, with $98.9 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Accumulated Depreciation & Amortization rose 24.51% year-over-year to $98.9 million, compared with a TTM value of $98.9 million through Dec 2024, up 24.51%, and an annual FY2024 reading of $98.9 million, up 24.51% over the prior year.
- Accumulated Depreciation & Amortization was $98.9 million for Q4 2024 at Medpace Holdings, up from $79.4 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $98.9 million in Q4 2024 and bottomed at $39.1 million in Q4 2020.
- Average Accumulated Depreciation & Amortization over 5 years is $66.1 million, with a median of $62.1 million recorded in 2022.
- The sharpest move saw Accumulated Depreciation & Amortization surged 30.67% in 2021, then rose 21.56% in 2022.
- Year by year, Accumulated Depreciation & Amortization stood at $39.1 million in 2020, then skyrocketed by 30.67% to $51.1 million in 2021, then grew by 21.56% to $62.1 million in 2022, then grew by 27.83% to $79.4 million in 2023, then rose by 24.51% to $98.9 million in 2024.
- Business Quant data shows Accumulated Depreciation & Amortization for MEDP at $98.9 million in Q4 2024, $79.4 million in Q4 2023, and $62.1 million in Q4 2022.